Quality of pharmacoeconomic research in China
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference53 articles.
1. Prescription drug spending: the impact of age and chronic disease status;Mueller;Am J Public Health,1997
2. Value-based medicine and pharmacoeconomics;Brown;Dev Ophthalmol,2016
3. Impact of pharmacoeconomics guidelines on the international publications in China;Rodrigues;Value Health,2014
4. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement;Husereau;Int J Technol Assess Health care,2013
5. A systematic review on the extent and quality of pharmacoeconomic publications for China;Jiang;Value Health Region Issues,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review;PharmacoEconomics - Open;2023-08-25
2. Were economic evaluations well reported for the newly listed oncology drugs in China’s national reimbursement drug list;BMC Health Services Research;2022-12-03
3. The quality of published health economic evaluations on screening programs in China: a systematic review and quantitative appraisal;Expert Review of Pharmacoeconomics & Outcomes Research;2022-10-13
4. Expanding the Global Outreach of Consolidated Health Economic Evaluation Reporting Standards 2022;Value in Health Regional Issues;2022-01
5. Pharmacoeconomics of obesity in China: a scoping review;Expert Review of Pharmacoeconomics & Outcomes Research;2021-02-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3